Methods for producing linear thiopeptides using an amino acid ortho
amino thioanilide compound
    3.
    发明授权
    Methods for producing linear thiopeptides using an amino acid ortho amino thioanilide compound 失效
    使用氨基酸邻氨基苯甲酰苯胺化合物生产线性硫代肽的方法

    公开(公告)号:US5457180A

    公开(公告)日:1995-10-10

    申请号:US258402

    申请日:1994-06-13

    申请人: Boulos Zacharie

    发明人: Boulos Zacharie

    摘要: The present invention provides methods for producing linear thiopeptides using an amino acid ortho amino thioanilide compound of formula (III) ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen or C.sub.1 -C.sub.4 branched or unbranched alkyl;R.sub.2 is selected from the group consisting of hydrogen, halo, amino, hydroxy, C.sub.1 -C.sub.4 branched or unbranched alkoxy, guanido, amido, acyl, carboxy, cyano, mercapto, nitro, azido, and C.sub.1 -C.sub.4 branched or unbranched alkyl optionally substituted by halo, amino, hydroxy, C.sub.1 -C.sub.4 branched or unbranched alkoxy, guanido, amido, acyl, carboxy, cyano, mercapto, nitro, azido;R.sub.3 is a decarboxylated amino acid residue or a decarboxylated amino acid chain comprising at least two amino acid residue.

    摘要翻译: 本发明提供使用式(III)的氨基酸邻氨基苯甲酰苯胺化合物(III)制备线性硫代肽的方法,其中R 1选自氢或C 1 -C 4支链或非支链烷基; R 2选自氢,卤素,氨基,羟基,C 1 -C 4支链或非支链烷氧基,胍基,酰氨基,酰基,羧基,氰基,巯基,硝基,叠氮基和任选取代的C 1 -C 4支链或非支链烷基 氨基,羟基,C 1 -C 4支链或非支链烷氧基,胍基,酰氨基,酰基,羧基,氰基,巯基,硝基,叠氮基; R3是包含至少两个氨基酸残基的脱羧氨基酸残基或脱羧氨基酸链。

    Soluble protein ZTMPO-1
    6.
    发明授权
    Soluble protein ZTMPO-1 失效
    可溶性蛋白质ZTMPO-1

    公开(公告)号:US06372889B1

    公开(公告)日:2002-04-16

    申请号:US09294531

    申请日:1999-04-19

    IPC分类号: C07K1447

    CPC分类号: C07K14/47 C07K14/66

    摘要: The present invention relates to polynucleotide and polypeptide molecules for ZTMPO-1, a novel soluble protein with homology to emerin and the thymopoietins. The polypeptides, and polynucleotides encoding them are useful for modulating cellular proliferation and differentiation and may be used for diagnostic purposes. The present invention also includes antibodies to the ZTMPO-1 polypeptides.

    摘要翻译: 本发明涉及用于ZTMPO-1的多核苷酸和多肽分子,其与emerin和胸腺细胞生成素具有同源性的新型可溶性蛋白质。 多肽和编码它们的多核苷酸可用于调节细胞增殖和分化,并可用于诊断目的。 本发明还包括针对ZTMPO-1多肽的抗体。

    Therapeutically active polypeptides or acid addition salts and a process
for producing such compounds
    7.
    发明授权
    Therapeutically active polypeptides or acid addition salts and a process for producing such compounds 失效
    治疗活性多肽或酸加成盐及其制备方法

    公开(公告)号:US4356119A

    公开(公告)日:1982-10-26

    申请号:US78424

    申请日:1979-09-24

    申请人: Hans Kofod

    发明人: Hans Kofod

    摘要: Polypeptide derivatives of the formula:a--x--b--y--cwherein x represents an acidic amino acid, preferably glu or asp,y represents a basic amino acid, preferably arg, lys or his,z represents hydrogen or a small protective group for the .alpha.-amino group in x,b represents a bond, a single amino acid or a peptide having up to 10 amino acids in the chain, andc represents --NR.sup.1 R.sup.2, wherein R.sup.1 and R.sup.2 are selected from the group consisting of hydrogen, C.sub.1 -C.sub.6 alkyl and C.sub.3 -C.sub.8 cycloalkyl, or R.sup.1 and R.sup.2 together with the attached nitrogen atom form a heterocyclic group optionally containing an additional hetero atom, orc represents --OR.sup.3, wherein R.sup.3 is selected from the group consisting of C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.8 cycloalkyl, benzyl, phenacyl, phthalimidomethyl, .beta.-methylthioethyl, 4-picolyl or substituted benzyl, orc is a single amino acid, except leu, or an amino acid derivative --z--d with the proviso that --z cannot be leu, and d may be --NR.sup.1 R.sup.2 or OR.sup.3, wherein R.sup.1, R.sup.2, and R.sup.3 are as defined above,or acid addition salts of such peptides, may be produced by peptide synthesis methods known per se.The polypeptides inhibit the glucose stimulated secretion of insulin from Langerhans's islets without affecting the secretion of glucagon, and potentiate the effect of insulin on the metabolism of glucose in isolated fat cells and in vivo potentiate the metabolism of glucose.

    摘要翻译: 下式的多肽衍生物:axbyc其中x表示酸性氨基酸,优选glu或asp,y表示碱性氨基酸,优选arg,lys或his,z表示氢或x中的α-氨基的小保护基 ,b表示键,单个氨基酸或链中具有至多10个氨基酸的肽,c表示-NR1R2,其中R1和R2选自氢,C1-C6烷基和C3-C8 环烷基或R 1和R 2与连接的氮原子一起形成任选地含有另外的杂原子的杂环基,或c表示-OR 3,其中R 3选自C 1 -C 6烷基,C 3 -C 8环烷基,苄基, 苯甲酰甲基,邻苯二甲酰亚氨基甲基,β-甲硫基乙基,4-吡啶甲基或取代的苄基,或c是除leu之外的单个氨基酸,或氨基酸衍生物,其条件是-z不能为leu,d可为-NR1R2或 OR3,其中R1,R2和R3如上定义,o 这种肽的R酸加成盐可以通过本身已知的肽合成方法产生。 多肽抑制葡萄糖刺激的胰岛素从朗格汉斯岛分泌而不影响胰高血糖素的分泌,并且增强胰岛素对分离的脂肪细胞中葡萄糖代谢的作用并且体内增强葡萄糖的代谢。

    Polypeptide compositions and methods
    8.
    发明授权
    Polypeptide compositions and methods 失效
    多肽组合物和方法

    公开(公告)号:US4190646A

    公开(公告)日:1980-02-26

    申请号:US6893

    申请日:1979-01-26

    摘要: There are disclosed polypeptide compositions having the following amino acid sequence as the active site:ARG-LYS-ASP-VAL-TYRThese polypeptides have the capability of inducing the differentiation of T-lymphocytes but not of complement receptor (CR.sup.+) B-lymphocytes and thus are useful in a number of therapeutic areas. Also provided are derivatives of the pentapeptide, novel intermediate polypeptides, methods of manufacture of the peptides, therapeutic compositions, and methods for use of the compositions.

    摘要翻译: 公开了具有以下氨基酸序列作为活性位点的多肽组合物:ARG-LYS-ASP-VAL-TYR这些多肽具有诱导T淋巴细胞分化而不是补体受体(CR +)B淋巴细胞分化的能力, 因此在许多治疗领域中是有用的。 还提供了五肽的衍生物,新的中间体多肽,肽的制备方法,治疗组合物和使用该组合物的方法。